Analysis of patients who received lamivudine for acute hepatitis B of genotype A

Kanzo/Acta Hepatologica Japonica

Volumn 48, Issue 4, 2007, Pages 145-152

  Omori, Kaku ^a   Torii, Nobuyuki ^a   Hasegawa, Kiyoshi ^b   Hashimoto, Etsuko ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Hasegawa Medical Clinic

Author keywords

Acute hepatitis B; Chronicity; Genotype A; Interferon; Lamivudine

Indexed keywords

ADEFOVIR; HEPATITIS B SURFACE ANTIGEN; INTERFERON; LAMIVUDINE; NEOMINOPHAGEN C;

ADOLESCENT; ADULT; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROCONVERSION; TREATMENT WITHDRAWAL;

EID: 53849110303     PISSN: 04514203     EISSN: None     Source Type: Journal    
DOI: 10.2957/kanzo.48.145     Document Type: Article

References (17)

1. Norder H, Courouce A, Magunius L. Complete genomes, phylogenic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994; 198: 489-503
2. Stuyver L, Gendt S, Geyt C, et al. A new genotype of hepatitis B virus; Complete genome and phylogenic relatedness. J Gen Virol 2000; 81: 67-74
3. Lindh M, Andersson A, Gusdul A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 1997; 175: 1285-1293
4. Orito E, Ichida T, Sakugawa H, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 2001; 34: 590-594
5. Mebio 2002 ; 37 : 34-38
6. Kobayashi M, Arase Y, Ikeda K, et al. Clinical feature of hepatitis B virus genotype A in Japanese patients. J Gastroenterol 2003; 38: 656-662
7. Japanese source
8. Joh R, Hasegawa K, Tokushige K, et al. Chronic hepatitis B with flare due to co-infection of hepatitis delta virus during lamivudine therapy. Int Med 2003; 42: 581-521
9. Torii N, Hasegawa K, Ogawa M, et al. Effectiveness and long-term outcome of lamivudine therapy for acute hepatitis B. Hepatol Res 2002; 357: 34-41
10. Ogawa M, Hasegawa K, Naritomi T, et al. Clinical features and viral sequence of various genotypes of hepatitis B virus compared among patients with acute hepatitis B. Hepatol Res 2002; 23: 167-177
11. Joh R, Hasegawa K, Ogawa M, et al. Genotypic analysis of hepatitis B virus from patients with fulminant hepatitis: comparison with acute self-limited hepatitis. Hepatol Res 2003; 26: 119-124
12. Reshef R, Sbeit W, Tur-Kaspa R, et al. Lamivudine in the Treatment of Acute hepatitis B. N Eng J Med 2004; 343: 1123-1124
13. Mizokami M, Nakano T, Orito E, et al. Hepatitis B virus genotype assignment using restriction fragment length polymorphism. FEBS Letters 1999; 450: 66-71
14. Hasegawa I, Tanaka Y, Anna K, et al. Novel hepatitis B virus genotype A subtyping assay that distinguishes subtype Aa from Ae and its application in epidemiological studies. J Virol 2004; 78: 7575-7581
15. Erhardt A, Blondin D, Hauck K, et al. Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D. Gut 2005; 54: 1009-1013
16. Suzuki Y, Kobayashi M, Ikeda K, et al. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan. J Med Virol 2005; 76: 33-39
17. Thio C, Mosburger T, Astemborski J, et al. Mannose binding lectin genotypes influence recovery from hepatitis B virus infection. J Virol 2005; 79: 9192-9196